1. Eidemüller M, Holmberg E, Jacob P, Lundell M, Karlsson P. Breast cancer risk and possible mechanisms of radiation-induced genomic instability in the Swedish hemangioma cohort after reanalyzed dosimetry. Mutat Res. 2015;775:1-9. 
  2. Wollschläger D, Karle H, Stockinger M, Bartkowiak D, Bührdel S, Merzenich H, Wiegel T, Blettner M, Schmidberger H. Radiation dose distribution in functional heart regions from tangential breast cancer radiotherapy. Radiother Oncol. 2016;119(1):65-70.
  3. Zvereva A, Petoussi-Henss N, Li WB, Schlattl H, Oeh U, Zankl M, Graner FP, Hoeschen C, Nekolla SG, Parodi K, Schwaiger M. Effect of blood activity on dosimetric calculations for radiopharmaceuticals. Phys Med Biol. 2016;61(21):7688-7703.
  4. Merzenich H, Bartkowiak D, Schmidberger H, Schmidt M, Schwentner L, Wiegel T, Woeckel A, Wollschläger D, Blettner M. 3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study). Breast Cancer Res Treat. 2017;161(1):143-152.
  5. Wollschläger D, Karle H, Stockinger M, Bartkowiak D, Bührdel S, Merzenich H, Wiegel T, Schmidberger H, Blettner M. Predicting heart dose in breast cancer patients who received 3D conformal radiation therapy. Health Phys. 2017;112(1):1-10.
  6. Wollschläger D, Merzenich H, Schwentner L, Janni W, Wiegel T, Bartkowiak D, Wöckel A, Schmidt M, Schmidberger H, Blettner M. Self-reported long-term cardiac morbidity in breast cancer patients: a retrospective cohort study in Germany (PASSOS Heart Study). Breast Cancer Res Treat. 2017;163(3):595-604.
  7. Simonetto C, Azizova TV, Barjaktarovic Z, Bauersachs J, Jacob P, Kaiser JC, Meckbach R, Schöllnberger H, Eidemüller M. A mechanistic model for atherosclerosis and its application to the cohort of Mayak workers. PLoS One. 2017;12(4):e0175386.
  8. Becker J. Beschreibung von Organgrenzen als Äquipotentialverlauf finiter Quellpunkte mit Q/r-Potentialen - Description of organ contours as equipotential lines of source points with a Q/r-potential (Doctoral dissertation). Technische Universität Ilmenau. 2015
  9. Zvereva A, Schlattl H, Zankl M, Becker J, Petoussi-Henss N, Yeom YS, Kim CH, Hoeschen C, Parodi K. Feasibility of reducing differences in estimated doses in nuclear medicine between a patient-specific and a reference phantom. Phys Med. 2017;39:100-112.
  10. Zvereva A, Advanced modeling for personalized dosimetry in nuclear medicine applications (Doctoral dissertation). Fakultät für Physik, Ludwig-Maximilians-Universität München. 2017.
  11. Zvereva A, Kamp F, Schlattl H, Zankl M, Parodi K. Impact of interpatient variability on organ dose estimates according to MIRD schema: Uncertainty and variance-based sensitivity analysis. Med Phys. 2018;45(7):3391-3403. 
  12. Kundrát P, Remmele J, Rennau H, Sebb S, Simonetto C, Eidemüller M, Wolf U, Hildebrandt G. Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy. Radiother Oncol. 2019;131:186-191.
  13. Simonetto C, Rennau H, Remmele J, Sebb S, Kundrát P, Eidemüller M, Wolf U, Hildebrandt G. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy. Strahlenther Onkol. 2019;195(1):32-42
  14. Castelletti N, Kaiser JC, Simonetto C, Furukawa K, Küchenhoff H, Stathopoulos GT. Risk of lung adenocarcinoma from smoking and radiation arises in distinct molecular pathways. Carcinogenesis. 2019;40(10):1240-1250.
  15. Castelletti N. Biological-based models of carcinogenesis in the lung from radiation and smoking. (Doctoral dissertation), Faculty of Mathematics, Computer Science and Statistics, Ludwig-Maximilians-Universität München 2019.
  16. Ulanowski A, Kaiser JC, Schneider U, Walsh L. On prognostic estimates of radiation risk in medicine and radiation protection. Radiat Environ Biophys. 2019;58(3):305-319.
  17. Kundrát P, Remmele J, Rennau H, Sebb S, Simonetto C, Eidemüller M, Wolf U, Hildebrandt G. Inter-Patient variability in doses to nearby organs in breast-cancer radiotherapy: Inference from anatomic features. Radiat Prot Dosimetry. 2019;183(1-2):255-258.
  18. Kundrát P, Simonetto C, Eidemüller M, Remmele J, Rennau H, Sebb S, Wolf U, Hildebrandt G. What anatomic features govern personal long-term health risks from breast-cancer radiotherapy? Radiat Prot Dosimetry. 2019;186(2-3):381-385.
  19. Eidemüller M, Simonetto C, Kundrát P, Ulanowski A, Shemiakina E, Güthlin D, Rennau H, Remmele J, Hildebrandt G, Wolf U. Long-term health risk after breast-cancer radiotherapy: Overview of PASSOS methodology and software. Radiat Prot Dosimetry. 2019;183(1-2):259-263.
  20. Eidemüller M, Holmberg E, Lundell M, Karlsson P. Evidence for increased susceptibility for breast cancer from exposure to ionizing radiation due to familial breast cancer history: results from the Swedish Hemangioma Cohort. American Journal of Epidemiology. 2021;190(1): 76–84.  
  21. Ulanowski A, Shemiakina E, Güthlin D, Becker J, Preston D, Apostoaei AI, Hoffman FO, Jacob P, Kaiser JC, Eidemüller M. ProZES: the methodology and software tool for assessment of assigned share of radiation in probability of cancer occurrence. Radiat Environ Biophys. 2020;59:601–629.
  22. Stockinger M, Karle H, Rennau H, Sebb S, Wolf U, Remmele J, Bührdel S, Bartkowiak D, Blettner M, Schmidberger H, Wollschläger D. Heart atlas for retrospective cardiac dosimetry: a multi-institutional study on interobserver contouring variations and their dosimetric impact. Radiation Oncology 2021Dec 20;16(1):241. doi 10.1186/s13014-021-01965-5.
  23. Simonetto C, Wollschläger D, Kundrát P, Ulanowski A, Becker J, Castelletti N, Güthlin D, Shemiakina E, Eidemüller M. Estimating long-term health risks after breast cancer radiotherapy: merging evidence from low and high doses.Radiat Environ Biophys 2021;60, 459–